Spruce Biosciences Files 8-K on Financials

Ticker: SPRB · Form: 8-K · Filed: Apr 1, 2025 · CIK: 1683553

Spruce Biosciences, Inc. 8-K Filing Summary
FieldDetail
CompanySpruce Biosciences, Inc. (SPRB)
Form Type8-K
Filed DateApr 1, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: financial-reporting, 8-K

Related Tickers: SPRU

TL;DR

SPRU filed an 8-K on March 31, 2025, detailing financial results.

AI Summary

Spruce Biosciences, Inc. filed an 8-K on April 1, 2025, reporting on its results of operations and financial condition as of March 31, 2025. The filing includes financial statements and exhibits related to the company's performance.

Why It Matters

This filing provides investors with an update on Spruce Biosciences' financial health and operational results as of the end of the first quarter of 2025.

Risk Assessment

Risk Level: low — This is a routine financial reporting filing and does not contain new material events or significant risk factors.

Key Players & Entities

  • Spruce Biosciences, Inc. (company) — Registrant
  • 0000950170-25-048726 (filing_id) — Accession Number
  • 20250401 (date) — Filing Date
  • 20250331 (date) — Period of Report
  • 611 Gateway Boulevard, Suite 740 (address) — Principal Executive Offices
  • South San Francisco, CA 94080 (address) — Principal Executive Offices
  • 415 294-1687 (phone_number) — Registrant's Telephone Number

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report on Spruce Biosciences, Inc.'s Results of Operations and Financial Condition and to provide Financial Statements and Exhibits as of March 31, 2025.

When was this 8-K filing submitted to the SEC?

This 8-K filing was submitted to the SEC on April 1, 2025.

What is the exact name of the company filing this report?

The exact name of the company filing this report is Spruce Biosciences, Inc.

What is the principal executive office address for Spruce Biosciences, Inc.?

The principal executive office address for Spruce Biosciences, Inc. is 611 Gateway Boulevard, Suite 740, South San Francisco, California 94080.

What is the Commission File Number for Spruce Biosciences, Inc.?

The Commission File Number for Spruce Biosciences, Inc. is 001-39594.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 1, 2025 regarding SPRUCE BIOSCIENCES, INC. (SPRB).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.